(Q39302489)

10 September 2017

Short courses of ofloxacin for the treatment of enteric fever (English)

1 reference

10 September 2017

1 reference

6

1 reference

10 September 2017

12

White NJ

1 reference

10 September 2017

9

Day NP

1 reference

10 September 2017

Nguyen TC

1

1 reference

10 September 2017

Solomon T

2

1 reference

10 September 2017

Mai XT

3

1 reference

10 September 2017

Nguyen TL

4

1 reference

10 September 2017

Nguyen TT

5

1 reference

10 September 2017

To SD

7

1 reference

10 September 2017

Smith MD

8

1 reference

10 September 2017

Le TP

10

1 reference

10 September 2017

Parry C

11

1 reference

10 September 2017

language of work or name

1 reference

1 May 1997

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

10 September 2017

1 reference

10 September 2017

91

1 reference

10 September 2017

3

1 reference

10 September 2017

347-349

1 reference

Effects on growth of single short courses of fluoroquinolones

10 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella typhi to treatment with trimethoprim-sulfamethoxazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

A randomized comparative study of fleroxacin and ceftriaxone in enteric fever

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Multiresistant Salmonella and fluoroquinolones.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Short-course treatment of typhoid fever with ciprofloxacin in south India

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Transferable Chloramphenicol Resistance in Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Open, prospective study of the clinical efficacy of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Ciprofloxacin-resistant Salmonella typhi in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Treatment of typhoid fever with ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2897%2990102-4

7 January 2021

10.1016/S0035-9203(97)90102-4

Identifiers

DOI

1 reference

10 September 2017

1 reference